During the past 12 months, Cleveland BioLabs's average Revenue per Share Growth Rate was -90.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -51.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -42.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -43.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Cleveland BioLabs was 204.40% per year. The lowest was -52.00% per year. And the median was -33.60% per year.
Competitive Comparison of Cleveland BioLabs's 3-Year Revenue Growth Rate
For the Biotechnology subindustry, Cleveland BioLabs's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleveland BioLabs's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cleveland BioLabs's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Cleveland BioLabs's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Cleveland BioLabs 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of Cleveland BioLabs's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Cleveland BioLabs (Cleveland BioLabs) Business Description
Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for the prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CBLI has been successfully added to your